SHARING IDEAS THAT DO GOOD

A Partnership to find a "one size fits all" cancer therapy

post-image

British scientists who announced last week their discovery of a new type of cancer-killing T-cell have entered a partnership with Ervaxx, a biotechnology company pioneering the use of Dark Antigens to develop T-cell receptor (TCR)-based immunotherapies and off-the-shelf cancer vaccines. The result—they hope—will be a “one-size-fits-all” cancer therapy.

https://www.forbes.com/sites/robinseatonjefferson/2020/01/28/new-partnership-could-lead-to-an-almost-instant-off-the-shelf-one-size-fits-all-cancer-treatment/

What do you think?

You must be logged in to post a comment.
Comments
Generic placeholder image

By Lynn Wood

31 January 2020



Related Posts

Healthcare

post-image

The dark matter of the gut microbiome for future therapeutics
11 June 2021 by Mel Raassina 0 Comments

Healthcare

post-image

Genomic test pinpoints Covid19 risk
3 June 2021 by Marty 1 Comments

Healthcare

post-image

Bone repair innovations using aquaculture farms
31 May 2021 by Mel Raassina 0 Comments